Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 301 - 350 out of 10,857

Document Document Title
WO/2013/009440A1
A process wherein an electron donor agent is provided for the decomposition of sulfones and sulfoxides formed after the oxidative desulfurization of a sulfur-containing hydrocarbon stream.  
WO/2012/116151A3
Compounds of formula II are described, wherein D, n, Ra, Rb, and Rc are as herein defined, along with pharmaceutical compositions and methods of using compounds of formula II for treating or reducing the risk of peritoneal carcinomatosis...  
WO/2012/176856A2
To provide a novel pesticide. The present invention provides a compound represented by the formula (I) or its salt, and a pesticide containing it as an active ingredient: (I) wherein each of R1 and R2 is a hydrogen atom, a halogen atom, ...  
WO/2012/171484A1
Disclosed is a substituted cyanoaniline compound or a salt thereof, wherein the compound has a structure represented by General Formula I. The compound of General Formula I has broad-spectrum fungicidal activity in the field of agricultu...  
WO/2012/174436A1
Disclosed are compounds which are nuclear receptor modulators that can act as antagonists to the androgen receptor, for example, a compound of Formula I: wherein R1 to R5 and X1 to X5 are as described herein, as well as pharmaceutically ...  
WO/2012/167869A1
The present invention provides new amino lipids and a convenient method for synthesising these compounds. These (cationic) amino lipids have good properties as transfection agents. The method is an economic versatile two step synthesis a...  
WO/2012/165314A1
The present invention provides an amide compound useful as a therapeutic agent for hypertension and the like. The present invention provides a compound represented by general formula (I) [wherein R1: an optionally substituted adamantyl g...  
WO/2012/165648A1
The present invention provides a compound having an excellent efficacy for controlling weeds. A cyclohexanone compound of the formula (I): wherein m is an integer of 1, 2 or 3; n is an integer of any one of 1 to 5; X represents CH2, O, S...  
WO/2012/154904A1
Disclosed are compounds that inhibit RNase H activity of retroviruses, for example, a compound of formula (I) wherein R1, R2, and R3 are as described herein, as well as pharmaceutically acceptable salts, solvates, stereoisomers, and prod...  
WO/2012/143337A1
The present invention relates to novel substituted phenoxyethylamine derivatives, useful as modulators of cortical and basal ganglia dopaminergic and N-methyl-D-aspartate (NMDA) receptor-mediated glutamatergic neurotransmission. In other...  
WO/2012/082551A3
Described herein is a composition according to formula I or its precursor, formula II: CX1X3=CX2-(R1)p-CZ1 Z2-SO2M (I) wherein X1, X2, and X3 are independently selected from H, F, Cl, Br, I, CF3 and CH3, and wherein at least one of X1, X...  
WO/2012/136428A1
Reactive dyes of formula (1), wherein R1 and R2 are each independently of the other hydrogen or unsubstituted or substituted C1-C4alkyl, one of the radicals D1 and D2 is a radical of the formula (2), the other one of the radicals D1 and ...  
WO/2012/136221A1
There is provided novel fluoro-substituted compounds capable of modulating the G- protein-coupled receptor GPR40, compositions comprising the compounds, and methods for their use for controlling insulin levels in vivo and for the treatme...  
WO/2012/119941A1
The invention relates to compounds of Formula (II) and their use in theraphy as peptidase inhibitors.  
WO/2012/087182A3
The invention relates to novel substituted methyl amines, serotonin 5-HT6 receptor antagonists, active ingredients, pharmaceutical compositions and a method for preventing and treating diseases of the central nervous system, as well as t...  
WO/2012/118441A1
The present invention provides an efficient and scalable process to prepare the compound of formula 4 by reduction of the corresponding α-acyloxy sulfides.  
WO/2012/116151A2
Compounds of formula II are described, wherein D, n, Ra, Rb, and Rc are as herein defined, along with pharmaceutical compositions and methods of using compounds of formula II for treating or reducing the risk of peritoneal carcinomatosis...  
WO/2012/108478A1
The present invention is a compound represented by formula (I) (in the formula, each of the reference numerals is as recited in the specification) or a salt thereof.  
WO/2012/032534A3
The present invention relates to compounds of formula XXII and their synthesis from furanose derivatives as shown hereunder. Compounds of formula XXII are of use in the synthesis of statins.  
WO/2012/098235A1
The invention relates to the molecule having formula (I), as well as the enantiomers thereof, and to the use of same in the treatment of ADHD, narcolepsy or idiopathic hypersomnia.  
WO/2012/089644A1
A process for preparing 3-alkylsulfinylbenzoyl derivatives of the formula (IIIa) by reaction of 3-alkylsulfinylbenzoic acids of the formula (Ib) with compounds of the formula (II) in the presence of a chlorinating agent and a base is des...  
WO/2012/085474A1
The present invention relates to a process for preparing chiral amino acids with excellent enantiomeric excesses.  
WO/2012/087182A2
The invention relates to novel substituted methyl amines, serotonin 5-HT6 receptor antagonists, active ingredients, pharmaceutical compositions and a method for preventing and treating diseases of the central nervous system, as well as t...  
WO/2012/082551A2
Described herein is a composition according to formula I or its precursor, formula II: CX1X3=CX2-(R1)p-CZ1 Z2-SO2M (I) wherein X1, X2, and X3 are independently selected from H, F, Cl, Br, I, CF3 and CH3, and wherein at least one of X1, X...  
WO/2012/081488A1
[Problem] To provide an acid catalyst which can reduce the quantity of waste in an organic synthesis reaction and which does not corrode a reactor and is nontoxic. [Solution] The problem is resolved by using a bis(trifluoromethanesulfony...  
WO/2012/072489A1
The invention relates to novel alpha,beta-unsaturated imines, to a method for producing same, to the use thereof for combating animal pests, including anthropods and in particular insects, and to the use thereof in vector control.  
WO/2012/069421A1
Compounds of general formula (I) their use as calcium receptor-active compounds for the prophylaxis, treatment or amelioration of physiological disorders or diseases associated with disturbances of CaSR activity, such as hyperparathyroid...  
WO/2012/026813A3
The invention relates to novel therapeutic compounds, more in particular to biologically active analogs of geranylgeranylacetone (GGA), and various use thereof. Provided is a compound of the general formula (II) and uses thereof as medic...  
WO/2012/042532A4
Processes for the preparation of N-[4-cyano-3-(trifluoro methyl) phenyl]-3-[(4-fluorophenyl) sulphonyl]-2-hydroxy-2- methyl propanamide or Bicalutamide are provided. A method for purifying the Bicalutamide using ethyl acetate solvent res...  
WO/2012/061926A1
The invention relates to bisarylsulfone and dialkylarylsulfone compounds (e.g., compounds according to any of Formulas (I)-(IX) or compounds (1)-(227) of Tables 4 and 5) useful in treating conditions associated with calcium channel funct...  
WO/2011/055381A8
The invention relates to the removal of the impact-sensitive and hazardous sodium azide (NaN3) salt along with ammonium chloride (NH4Cl) for the recovery of dimethyl sulfoxide (DMSO) solvent present in a pharmaceutical industrial effluen...  
WO/2012/055034A1
Compounds of Formula I are disclosed: wherein L, A, R1, R2, R3A, R3B, R4A, R4B, R5, R6 and R7 are defined herein. The compounds encompassed by Formula I include compounds which are HIV protease inhibitors and other compounds which can be...  
WO/2012/054526A2
Provided herein are methods for treating conditions associated with a chemosensory receptor, including diabetes, obesity, and other metabolic diseases, disorders or conditions by administering a composition comprising a chemosensory rece...  
WO/2012/054521A2
The present application describes compounds of Formula I and Formula IA and as disclosed herein, that are useful as anti-microbial agents, including as antibacterial, disinfectant, antifungal, germicidal or antiviral agents.  
WO/2012/046771A1
The inventors have intensively studied on compounds that have Aβ42 production inhibitory activity and have found that a compound (I) of the present invention, wherein a carboxylic acid or a tetrazole group is bonded to a cycloalkane moi...  
WO/2012/042532A1
Processes for the preparation of N-[4-cyano-3-(trifluoro methyl) phenyl]-3-[(4-fluorophenyl) sulphonyl]-2-hydroxy-2- methyl propanamide or Bicalutamide are provided. A method for purifying the Bicalutamide using ethyl acetate solvent res...  
WO/2011/071951A3
The invention provides certain N-acyloxysulfonamide and N-hydroxy-N-acylsulfonamide derivative compounds, pharmaceutical compositions and kits comprising such compounds, and methods of using such compounds or pharmaceutical compositions....  
WO/2012/034472A1
Cyano benzenedicarboxamide compounds of formula (I), preparing methods and as agricultural insecticides uses thereof. The compounds have broad-spectrum insecticidal activities.  
WO/2012/036257A1
Provided is a composition for maintaining platelet function that has as the active ingredient a compound represented by general formula (I) [in the formula: X indicates a phenylene group; Y indicates a hydrogen atom or -(CH2)mR1; m indic...  
WO/2012/032534A2
The present invention relates to Furanose derivatives and their applications in synthesis of statins.  
WO/2012/033225A1
The present invention relates to a novel method for producing a pyridazinone compound and an intermediate thereof as shown in the following scheme: wherein the symbols are as defined in the specification.  
WO/2012/031196A1
The present invention relates to compounds and compositions for the inhibition of NAMPT, their synthesis, applications and antidotes. An embodiment of the invention is the provision of a compound of Formula IIIA.  
WO/2012/026813A2
The invention relates to novel therapeutic compounds, more in particular to biologically active analogs of geranylgeranylacetone (GGA), and various use thereof. Provided is a compound of the general formula (II) and uses thereof as medic...  
WO/2011/129967A3
The description includes materials that may be useful for fuel cell applications such as in the manufacture of fuel cell electrodes, proton exchange membranes (PEM), as catalyst additives or in tie layers designed to be thermally and che...  
WO/2012/020483A1
A 3-aminooxalyl aminobenzamide derivative used in an insecticide and miticide is provided. The 3-aminooxalyl aminobenzamide derivative is represented by the following formula. (In the formula, R1 represents a C1 to C3 halo alkylthio grou...  
WO/2012/004443A8
The invention relates to compounds which are active pharmaceutical principles used for treating and/or preventing inflammation and/or cancer, having formula (I) in which -X- is a single bond, -NH- or -CO-, and -Ar is an aromatic radical ...  
WO/2012/016779A1
Sulphur-containing and sulphone-containing aromatic perfluoroalkane monomer that can be used for the manufacture of a polymer membrane intended for a fuel cell of PEM type, said functionalized monomer corresponding to the formula (I): E1...  
WO/2012/010575A1
The invention relates to (4-halogenalkyl-3-thiobenzoyl)cyclohexanediones of general formula (I) and to the use thereof as herbicides. In said formula (I), X, Y, R1, R2, R3 and R4 represent radicals such as hydrogen and organic radicals s...  
WO/2012/010574A1
The invention relates to (4-trifluormethyl-3-thiobenzoyl)cyclohexanediones of general formula (I) and use thereof as herbicides. In said formula (I) X, R1, R2, R3 and R4 represent radicals such as hydrogen and organic radicals such as al...  
WO/2012/010644A1
Process for the synthesis of an isothiocyanate of general formula (I) SCN‑R1-R4-R2 in which R1 and R2 represent, independently of one another, an alkyl, aryl or alkylaryl group, R4 represents a carbonyl, sulphinyl or sulphonyl group or...  

Matches 301 - 350 out of 10,857